C12N 2760/16123
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/16123 (Virus like particles [vlp]) appears on 122 US grants and 205 published applications in this corpus.
Search patents in C12N- Granted patents
- 122
- Published applications
- 205
- Assignees
- 92
- Inventors
- 255
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 4 |
| 2007 | 0 | 3 |
| 2008 | 0 | 1 |
| 2009 | 2 | 5 |
| 2010 | 1 | 13 |
| 2011 | 2 | 7 |
| 2012 | 1 | 6 |
| 2013 | 5 | 15 |
| 2014 | 8 | 14 |
| 2015 | 11 | 13 |
| 2016 | 13 | 16 |
| 2017 | 12 | 17 |
| 2018 | 14 | 12 |
| 2019 | 13 | 15 |
| 2020 | 8 | 11 |
| 2021 | 8 | 12 |
| 2022 | 4 | 9 |
| 2023 | 4 | 7 |
| 2024 | 9 | 8 |
| 2025 | 5 | 4 |
| 2026 | 1 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Virus-like particles containing CST1 protein and toxoplasma vaccine using same1 Sep 2026US 12,721,886 B2University-Industry Cooperation Group of Kyung Hee University
- Influenza virus-like particle production in plants11 Nov 2025US 12,467,058 B2Aramis Biotechnologies Inc.
- Influenza virus hemagglutinin mutants30 Sep 2025US 12,428,661 B2Aramis Biotechnologies Inc.
- Mosaic influenza virus hemagglutinin polypeptides and uses thereof22 Jul 2025US 12,364,746 B2Icahn School of Medicine at Mount Sinai
- Proliferation method20 May 2025US 12,305,197 B2Kao Corporation
- Mosaic influenza virus hemagglutinin polypeptides and uses thereof30 Jul 2026US 2026/0216314 A1Icahn School of Medicine at Mount Sinai
- Purification of viruses, virus-like particles, and globular biomolecules by filtration-supported polyalkylene glycol precipitation30 Jul 2026US 2026/0216667 A1
- Rna encoding virus-like particles and uses thereof5 Feb 2026US 2026/0034204 A1Seqirus Inc.
- Pseudo-viral particles and uses of same5 Feb 2026US 2026/0034210 A1Angany Inc.
- Low dose vaccine compositions29 Jan 2026US 2026/0027196 A1Centivax, Inc.
Most cited
By later US patents
- Assembly of wild-type and chimeric influenza virus-like particles (VLPs)48US 7,556,940 B2Wyeth Holdings Corporation · 2009
- Functional influenza virus-like particles (VLPs)35US 7,763,450 B2Novavax, Inc. · 2010
- Functional influenza virus like particles (VLPs)35US 8,080,255 B2Novavax, Inc. · 2011
- Viruses encoding mutant membrane protein33US 7,588,769 B2Wisconsin Alumni Research Foundation · 2009
- Functional influenza virus like particles (VLPs)20US 8,506,967 B2Novavax, Inc. · 2013